Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
JCS 2021 Guideline on Radiation Safety in Cardiology.
Kozuma K, Chikamori T, Hashimoto J, Honye J, Ikeda T, Ishiwata S, Kato M, Kondo H, Matsubara K, Matsumoto K, Matsumoto N, Motoyama S, Obunai K, Sakamoto H, Soejima K, Suzuki S, Abe K, Amano H, Hioki H, Iimori T, Kawai H, Kosuge H, Nakama T, Suzuki Y, Takeda K, Ueda A, Yamashita T, Hirao K, Kimura T, Nagai R, Nakamura M, Shimizu W, Tamaki N; Japanese Circulation Society Joint Working Group. Kozuma K, et al. Among authors: yamashita t. Circ J. 2022 Jun 24;86(7):1148-1203. doi: 10.1253/circj.CJ-21-0379. Epub 2022 Apr 22. Circ J. 2022. PMID: 35466155 Free article. No abstract available.
Detection of late responders from non-responders to apremilast by simply measuring pruritus at week 4: results from a prospective cohort observational study.
Fukasawa T, Yoshizaki-Ogawa A, Enomoto A, Yamashita T, Miyagawa K, Sato S, Yoshizaki A. Fukasawa T, et al. Among authors: yamashita t. J Am Acad Dermatol. 2024 May 14:S0190-9622(24)00747-3. doi: 10.1016/j.jaad.2024.05.015. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38754631 No abstract available.
Neprilysin inhibition promotes skeletal growth via the CNP/NPR-B pathway.
Hakata T, Ueda Y, Yamashita T, Yamauchi I, Kosugi D, Sugawa T, Fujita H, Okamoto K, Fujii T, Taura D, Yasoda A, Akiyama H, Inagaki N. Hakata T, et al. Among authors: yamashita t. Endocrinology. 2024 May 16:bqae058. doi: 10.1210/endocr/bqae058. Online ahead of print. Endocrinology. 2024. PMID: 38752331
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD.
Ikeda M, Yamashita T, Ogasawara S, Kudo M, Inaba Y, Morimoto M, Tsuchiya K, Shimizu S, Kojima Y, Hiraoka A, Nouso K, Aikata H, Numata K, Sato T, Okusaka T, Furuse J. Ikeda M, et al. Among authors: yamashita t. Liver Cancer. 2023 Jul 7;13(2):193-202. doi: 10.1159/000531820. eCollection 2024 Apr. Liver Cancer. 2023. PMID: 38751550 Free PMC article.
Construction of a screening system for lipid-derived radical inhibitors and validation of hit compounds to target retinal and cerebrovascular diseases.
Mori R, Abe M, Saimoto Y, Shinto S, Jodai S, Tomomatsu M, Tazoe K, Ishida M, Enoki M, Kato N, Yamashita T, Itabashi Y, Nakanishi I, Ohkubo K, Kaidzu S, Tanito M, Matsuoka Y, Morimoto K, Yamada KI. Mori R, et al. Among authors: yamashita t. Redox Biol. 2024 May 8;73:103186. doi: 10.1016/j.redox.2024.103186. Online ahead of print. Redox Biol. 2024. PMID: 38744193 Free article.
6,784 results